alexa Oncolytic HSV-1 Therapy For Cancer
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th World Congress on Virology
October 06-08, 2014 Hilton San Antonio Airport, TX, USA

Accepted Abstracts: J Antivir Antiretrovir
DOI: 10.4172/1948-5964.S1.022
Oncolytic HSV-1 derived vectors hold promise for treating cancer patients. Deletion of specific viral genes renders the virus able to efficiently replicate in malignant cells but not in normal cells. This has the potential to lead to lytic destruction of cancers with minimal damage to surrounding non neoplastic tissue. Consequences of viral genes frequently attenuated in vectors currently being tested in patients will be discussed. Arming Oncolytic viruses with gene therapy delivering a therapeutic payload is another investigational strategy which has shown promise in multiple preclinical studies. This approach is particularly advantageous when therapeutic payload is secreted and can affect infected and uninfected cells. Here we will also discuss the biology of brain angiogenesis inhibitor 1, and its extracellular fragment called vstat120. Expression of Vstat120 in tumors reduces angiogenesis and tumorigenesis. We have created second and third generation viruses that are capable of delivering Vstat120 thus countering tumor angiogenesis while leading to its lytic destruction. Therapeutic implications for this approach will be discussed.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version